Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.
Google’s Parent Company (Alphabet) Funds New Gene Editing Company An article recently published in MIT Review reports that Verve Therapeutics announced that it has received funding from Alphabet’s GV venture fund plus…
Continue Reading
Google’s Parent Company (Alphabet) Funds New Gene Editing Company
Google Backs Startup For Treating Heart Disease Via CRISPR Injections May 16, 2019 --Sharing is Caring-- Google Backs Startup For Treating Heart Disease Via CRISPR Injections Once in our life…
Continue Reading
Google Backs Startup For Treating Heart Disease Via CRISPR Injections
An estimated thirty million people in the U.S. are affected by chronic kidney disease. That translates into one out of three adults who are at risk. The majority, however,…
Continue Reading
Investigational Catheter Lock Solution Reduces Infections for Dialysis Patients
China’s attempt to stem the tide of drug addiction through brain surgery has been problematic. Yet a recent article in the Himalayan Times reports that six of the eight…
Continue Reading
At The Crossroads: The Opioid Crisis vs. Brain Implants (A “Pacemaker” for the Brain)
Pharmaceutical companies have spent billions of dollars on Alzheimer’s research. The target has been the toxic protein, amyloid-beta. According to a recent article in NPR News, this theory was…
Continue Reading
ALZHEIMER’S: Scientists are Back to Square One; Will Bryostatin-1 be the Missing Link?
A recent article in the neuroscience section of the Medical Express reports the results of a study conducted by researchers in the Charcot-Marie-Tooth/Hereditary Neuropathy Center at internationally acclaimed Cedars-Sinai.…
Continue Reading
New Research With the Potential to Alleviate Symptoms of Parkinson’s, Alzheimer’s and Charcot-Marie-Tooth Disorders
Three stories of courage are highlighted in Orlando Family Magazine’s annual tribute to the medical community. The first example relates to a mother, Eva, for her courage in opting…
Continue Reading
Three Inspiring Stories of Courage
It has been less than two years since Cytokinetics’ previous ALS muscle drug, tirasemtiv, failed to meet its endpoint in a Phase III trial to treat ALS. (That was after…
Continue Reading
A Biotech Company Finds a Silver Lining After Clinical Trial Results Show Failure of its New ALS Drug
A recent article in CBC News describes the heartbreak and struggle of a Canadian couple appealing to the Canadian government to fund medication for their younger son. Both their children, Andre…
Continue Reading
Parents are Worried That Only One of Their Two Children Will Get Access to Cystic Fibrosis Drug
An article in Globe Newswire quotes National Institute of Health statistics for malaria as being between 300 to 500 million cases worldwide resulting in 1.5 to 2.7 million deaths annually. People living…
Continue Reading
MALARIA: Between One Million and Two Million Deaths Each Year Worldwide. This Company is on Target to Treat Severe Malaria
A recent report that was published in the Swiss Medical Weekly outlines data gathered by a Swiss panel of experts on plasma cell myeloma. The report offers an update and…
Continue Reading
New Data on the Difference Between Plasma Cell Myeloma and Smoldering Myeloma Has Treatment Implications
The News Hub at Washington State University recently carried an article describing initial success by researchers towards developing a drug for a rare form of muscular dystrophy. Several thousand people…
Continue Reading
Researchers Believe Lithium May be Key to Developing a Drug for Limb Girdle Muscular Dystrophy
Researcher: “MND is not an incurable disease. It is an underfunded disease” The Trinity Times recently interviewed Prof. Orla Hardiman on the subject of motor neuron disease (MND), also…
Continue Reading
Researcher: “MND is Not an Incurable disease. It is an Underfunded Disease”
A recent posting by the Leukemia and Lymphoma Society references the Beat AML Master Trial. The trial evaluates targeted therapies to treat acute myeloid leukemia (AML) and was launched…
Continue Reading
The LLS Ground-Breaking Precision Medicine Approach Master Trial BEAT AML Releases Third Year Test Results
In about five years India’s population will exceed that of China which is currently ranked number one according to population. Contrast these numbers with the fact that only ten percent…
Continue Reading
Rare Diseases: Only 10% of India’s 1.37 Billion People Have Health Insurance
Dr. David Porteous, a General Practitioner in Bristol, England recently reported to the Bristol Cable, a community-run newspaper, that he does not agree with the extensive list of treatments being…
Continue Reading
GPs and Specialists in UK are Challenging the Restrictions That Deny Patients Access to Treatment
Ash Clinical News recently interviewed Dr. Bruce Leff of Johns Hopkins in connection with “hospital-at-home”, one of the major changes occurring in hospital care. Dr. Leff and his team at…
Continue Reading
In-Patient Hospitalization vs. At-Home Programs: Will Doctors Be Making House Calls Again?
According to an article in Biospace, the FDA is currently reviewing data from the Phase III STRIVE clinical trial for possible approval of Zolgensma as gene therapy for spinal…
Continue Reading
New Drug Under Review by the FDA to Treat the Most Lethal Form of Spinal Muscular Atrophy
Just one year ago David Chen, a forty-year-old policeman who lives in Toronto, was walking home after playing volleyball. According to a recent article in CBC Canada News, a…
Continue Reading
The FDA Rejects a Therapeutic Device that Stimulates Cranial Nerves
Although guidelines for Parkinson’s patients suggest that they visit a specialist every six months, according to a report in Parkinson’s News Today, the waiting period may be up to…
Continue Reading
New Personal Kinetigraph (PKG) Allows Parkinson’s Patients in the UK to Connect with their Specialists
Lithium boosts muscle strength in mice with rare muscular dystrophy New drug target identified Click to share on Pinterest (Opens in new window) Removing one gene caused normal muscle muscle…
Continue Reading
Lithium boosts muscle strength in mice with rare muscular dystrophy
The mesothelioma diagnosis was a surprise to Raya Bodnarchuk of Baltimore, Maryland because she had never worked in a factory, mine, the military, or a shipyard. These are the typical…
Continue Reading
First Bronchitis, Then Pneumonia, Then the Stunning Diagnosis: Mesothelioma
A birth involving mitochondrial replacement therapy took place as part of a clinical trial in Greece according to a recent article in STAT. Greece is now the second country…
Continue Reading
Can the Mitochondrial Replacement Therapy Ban in the U.S. Be Lifted?
Familial Hypercholesterolemia (FH) is often misdiagnosed as plain old high cholesterol because of overlapping symptoms such as elevated lipid levels. According to a recent article in MedicalView, FH is three…
Continue Reading
Artificial Intelligence(AI) and a Solution to Detect Familial Hypercholesterolemia
A three-year research grant of $11 million has been awarded through the Gilbert Family Foundation in America. According to a recent article in News-Medical Life Sciences, the Foundation was formed…
Continue Reading
A Team of Scientists Researching A Cure for Neurofibromatosis Type 1